Developer docs
API playgroundTry for free, no card

Search company profiles

Vastrax

Full company profile

uuid000n5p2

Namestring
Vastrax
Legal namestring
Vastrax, Inc.
Websiteurl
vastrax.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Vastrax, Inc. is a global full-service Contract Research Organization (CRO) exclusively dedicated to supporting the clinical development of neurological therapies. Founded in 2016 and headquartered in Waltham, Massachusetts, the company serves pharmaceutical sponsors, biotechnology companies, and neuro device startups running trials across stroke (ischemic, hemorrhagic, neuroprotective), aneurysm (flow-diversion and embolic devices), neuro-pharma, brain-computer interface, AI-powered diagnostic imaging, neuromodulation, robotics, spine, and micro-access tools. Its core service portfolio spans trial operations, regulatory expertise (US and EU), study design, clinical monitoring, biometrics, elite site partnerships, safety, and consulting — offered either as end-to-end program management or as targeted gap-fill support.

The company operates as a professional services firm rather than a technology product company; its differentiated capability rests on a team of 50+ seasoned clinical research professionals averaging 15+ years of experience who have collectively supported 125+ neuro programs including landmark studies and multiple product approvals. AI is used narrowly within biometrics to surface program trend insights across large multinational trials. Revenue is generated through negotiated, quote-based B2B contracts with sponsors, with no public pricing disclosed; the go-to-market is enterprise field sales driven by therapeutic-area credibility, KOL and elite investigator relationships, and a validated regulatory posture that includes successful FDA audits at both organizational and study-site levels.

Vastrax is privately held with no disclosed parent company, institutional investors, or venture funding in the available source material, and no current job openings are listed on its careers page. Ownership, leadership team details beyond the founder/president, and any quantitative financial metrics (revenue, headcount time-series, contract values) are not evidenced in the input data, limiting external triangulation of scale and growth.

Short descriptiontext

Vastrax is a global full-service CRO exclusively focused on neurological therapies, serving pharma sponsors, biotechs, and neuro device startups with trial operations, regulatory, biometrics, and elite site network services across stroke, aneurysm, BCI, AI-imaging, and neuromodulation programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWaltham, United States
HQ citystring
Waltham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, neurology CRO, neurovascular trials, biometrics analysis, regulatory affairs
Industry2 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services (Contract Research Organization)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1CRO Services - Professional Services
TypeProfessional Services
Description

Vastrax provides comprehensive global CRO services including trial operations, regulatory expertise, study design, clinical monitoring, biometrics, site partnerships, and safety services. Revenue is generated through professional services contracts with pharmaceutical sponsors, biotech companies, and neuro device startups. Services are tailored to client needs from end-to-end study management to filling targeted gaps.

vastrax.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Personnel
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Vastrax is a global full-service Contract Research Organization (CRO) exclusively supporting the development of neurological therapies. It delivers a comprehensive suite of integrated services—Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics, Elite Site Partnerships, and Safety Services—to pharmaceutical sponsors, biotech companies, and neuro device startups across stroke, aneurysm, AI-imaging, brain-computer interface, neuromodulation, spine, and neuro-pharma programs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Vastrax is a global full-service Contract Research Organization (CRO) exclusively focused on neurological therapies. The company offers a comprehensive suite of integrated services including Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics (with AI-enabled insights), Elite Site Partnerships, and Safety Services. Their service portfolio is organized around core functional areas that work together across the clinical development lifecycle. Vastrax specializes in multiple neuro indication areas: Stroke (ischemic, hemorrhagic, neuroprotective), Aneurysm (flow-diversion and embolic devices), Neuro-Pharma (small-molecule, biologic, gene-based treatments), Brain-Computer Interface (BCI/BMI), Imaging/AI, Neuromodulation, robotics, spine, and micro-access tools. The company combines the scale of a global organization with boutique partner agility to deliver faster activations and cleaner data for neurological clinical programs.

Product and service8 records
1Trial Operations
CategoryClinical Operations
Description

Oversees all program phases with clear timelines and consistent communication for pharmaceutical sponsors, biotech companies, and neuro device startups running neurological clinical trials.

2Regulatory Expertise
CategoryRegulatory Affairs
Description

Provides extensive US and EU regulatory experience, guiding clinical sponsors through regulatory interactions with proactive planning to position programs for success.

3Study Design
CategoryClinical Development
Description

Provides comprehensive design input including protocol refinement and endpoint selection that reduces risk and positions neurological trials for faster approvals.

4Clinical Monitoring
CategoryClinical Operations
Description

Global clinical monitoring team averaging 15+ years of experience, ensuring quality data through consistent oversight across neurological trial sites.

5Biometrics
CategoryData and Biostatistics
Description

Designs efficient analysis plans and proactively manages complex datasets with speed, transparency, and accuracy, integrating AI-enabled insights to surface program trends in large multinational neurological studies.

6Elite Site Partnerships
CategorySite Management
Description

Provides clinical sponsors access to elite investigators and veteran coordinators at established global sites to keep neurological trials on track with quality data.

7Safety Services
CategoryPharmacovigilance
Description

Safeguards subject well-being and ensures regulatory compliance and data integrity across neurological clinical programs.

8Consulting & Study Design
CategoryConsulting
Description

Brings decades of neurovascular trial experience to assist sponsors in refining protocols, selecting endpoints, and preparing regulatory packages for neurological therapies.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Mid-sized digital CRO focused on emerging and mid-market biotech and device sponsors. Overlaps with Vastrax in therapeutic-area expertise-driven service model and BCI/neuro device startup customer profile.

TypeDirect peer
Description

Specialty CRO focused on biotech and device sponsors with strong CNS and rare disease capabilities. Closely comparable in therapeutic-area specialization and customer profile to Vastrax.

TypeDirect peer
Description

Specialty CRO with deep expertise in neuroscience, rare disease, and complex clinical programs. Competes with Vastrax for neuro-focused study design, regulatory strategy, and global trial execution.

TypeDirect peer
Description

Specialty CRO with deep expertise in neurology, rare disease, and medical device trials. Competes head-to-head with Vastrax for neuro-focused study design, regulatory navigation, and global clinical monitoring work.

5Veristat
TypeDirect peer
Description

Specialty clinical and biometrics CRO serving small and mid-sized biotech and device sponsors with complex trial designs. Comparable to Vastrax in serving niche, expertise-intensive neuro programs with high-touch engagement.

TypeBroad incumbent
Description

Global full-service CRO with significant CNS and neuro device exposure via the PRA Health Sciences combination. Competes for large neuro trials where scale, geographic reach, and integrated technology platforms matter.

TypeBroad incumbent
Description

Largest global CRO with broad neuroscience practice and dedicated neuro operations. Competes with Vastrax on enterprise neuro trials but offers materially deeper resourcing and a broader therapeutic portfolio.

TypeBroad incumbent
Description

Large global CRO with established neurology practice and strong medical device trial capabilities. Overlaps with Vastrax in neurovascular device and neuro-pharma trial execution but at significantly larger scale.

TypeBroad incumbent
Description

Mid-to-large full-service CRO with growing neuroscience and neuro device capabilities and a global operating footprint. Competes with Vastrax on full-service neuro trials but at meaningfully greater scale and geographic reach.

TypeDirect peer
Description

Mid-sized global CRO with a well-established neuroscience franchise spanning CNS trials and rare neurological disease. Direct competitor for Vastrax in neuro-focused clinical operations, biometrics, and regulatory services to pharma and device sponsors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vastrax

Clinical Research Services (Contract Research Organization)vastrax.com

Vastrax is a global full-service CRO exclusively focused on neurological therapies, serving pharma sponsors, biotechs, and neuro device startups with trial operations, regulatory, biometrics, and elite site network services across stroke, aneurysm, BCI, AI-imaging, and neuromodulation programs.

What Vastrax does

Vastrax, Inc. is a global full-service Contract Research Organization (CRO) exclusively dedicated to supporting the clinical development of neurological therapies. Founded in 2016 and headquartered in Waltham, Massachusetts, the company serves pharmaceutical sponsors, biotechnology companies, and neuro device startups running trials across stroke (ischemic, hemorrhagic, neuroprotective), aneurysm (flow-diversion and embolic devices), neuro-pharma, brain-computer interface, AI-powered diagnostic imaging, neuromodulation, robotics, spine, and micro-access tools. Its core service portfolio spans trial operations, regulatory expertise (US and EU), study design, clinical monitoring, biometrics, elite site partnerships, safety, and consulting — offered either as end-to-end program management or as targeted gap-fill support.

The company operates as a professional services firm rather than a technology product company; its differentiated capability rests on a team of 50+ seasoned clinical research professionals averaging 15+ years of experience who have collectively supported 125+ neuro programs including landmark studies and multiple product approvals. AI is used narrowly within biometrics to surface program trend insights across large multinational trials. Revenue is generated through negotiated, quote-based B2B contracts with sponsors, with no public pricing disclosed; the go-to-market is enterprise field sales driven by therapeutic-area credibility, KOL and elite investigator relationships, and a validated regulatory posture that includes successful FDA audits at both organizational and study-site levels.

Vastrax is privately held with no disclosed parent company, institutional investors, or venture funding in the available source material, and no current job openings are listed on its careers page. Ownership, leadership team details beyond the founder/president, and any quantitative financial metrics (revenue, headcount time-series, contract values) are not evidenced in the input data, limiting external triangulation of scale and growth.

Vastrax firmographics

Firmographics
Name
Vastrax
Legal name
Vastrax, Inc.
Website
https://vastrax.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Vastrax is a global full-service CRO exclusively focused on neurological therapies, serving pharma sponsors, biotechs, and neuro device startups with trial operations, regulatory, biometrics, and elite site network services across stroke, aneurysm, BCI, AI-imaging, and neuromodulation programs.
Ownership category
akta.pro rank

Vastrax industry classification

Industry
Product category
Clinical Research Services (Contract Research Organization)
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Clinical research services
  • Neurology CRO
  • Neurovascular trials
  • Biometrics analysis
  • Regulatory affairs

Where Vastrax is headquartered

Location

Headquarters

HQ city
Waltham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vastrax business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel

Revenue model

  1. CRO Services - Professional Services: Vastrax provides comprehensive global CRO services including trial operations, regulatory expertise, study design, clinical monitoring, biometrics, site partnerships, and safety services. Revenue is generated through professional services contracts with pharmaceutical sponsors, biotech companies, and neuro device startups. Services are tailored to client needs from end-to-end study management to filling targeted gaps.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Vastrax product offering

Product offering

Core offering

Vastrax is a global full-service Contract Research Organization (CRO) exclusively supporting the development of neurological therapies. It delivers a comprehensive suite of integrated services—Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics, Elite Site Partnerships, and Safety Services—to pharmaceutical sponsors, biotech companies, and neuro device startups across stroke, aneurysm, AI-imaging, brain-computer interface, neuromodulation, spine, and neuro-pharma programs.

Product overview

Vastrax is a global full-service Contract Research Organization (CRO) exclusively focused on neurological therapies. The company offers a comprehensive suite of integrated services including Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics (with AI-enabled insights), Elite Site Partnerships, and Safety Services. Their service portfolio is organized around core functional areas that work together across the clinical development lifecycle. Vastrax specializes in multiple neuro indication areas: Stroke (ischemic, hemorrhagic, neuroprotective), Aneurysm (flow-diversion and embolic devices), Neuro-Pharma (small-molecule, biologic, gene-based treatments), Brain-Computer Interface (BCI/BMI), Imaging/AI, Neuromodulation, robotics, spine, and micro-access tools. The company combines the scale of a global organization with boutique partner agility to deliver faster activations and cleaner data for neurological clinical programs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Trial Operations Oversees all program phases with clear timelines and consistent communication for pharmaceutical sponsors, biotech companies, and neuro device startups running neurological clinical trials.
  • Regulatory Expertise Provides extensive US and EU regulatory experience, guiding clinical sponsors through regulatory interactions with proactive planning to position programs for success.
  • Study Design Provides comprehensive design input including protocol refinement and endpoint selection that reduces risk and positions neurological trials for faster approvals.
  • Clinical Monitoring Global clinical monitoring team averaging 15+ years of experience, ensuring quality data through consistent oversight across neurological trial sites.
  • Biometrics Designs efficient analysis plans and proactively manages complex datasets with speed, transparency, and accuracy, integrating AI-enabled insights to surface program trends in large multinational neurological studies.
  • Elite Site Partnerships Provides clinical sponsors access to elite investigators and veteran coordinators at established global sites to keep neurological trials on track with quality data.
  • Safety Services Safeguards subject well-being and ensures regulatory compliance and data integrity across neurological clinical programs.
  • Consulting & Study Design Brings decades of neurovascular trial experience to assist sponsors in refining protocols, selecting endpoints, and preparing regulatory packages for neurological therapies.

Companies that use Vastrax

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles1 record

Vastrax technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Vastrax partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Vastrax competitors and assessment

Company assessment

Emerging players

  • Clinipace Worldwide: Mid-sized digital CRO focused on emerging and mid-market biotech and device sponsors. Overlaps with Vastrax in therapeutic-area expertise-driven service model and BCI/neuro device startup customer profile.

Direct peers

  • Precision for Medicine: Specialty CRO focused on biotech and device sponsors with strong CNS and rare disease capabilities. Closely comparable in therapeutic-area specialization and customer profile to Vastrax.
  • CTI Clinical Trial and Consulting Services: Specialty CRO with deep expertise in neuroscience, rare disease, and complex clinical programs. Competes with Vastrax for neuro-focused study design, regulatory strategy, and global trial execution.
  • Premier Research: Specialty CRO with deep expertise in neurology, rare disease, and medical device trials. Competes head-to-head with Vastrax for neuro-focused study design, regulatory navigation, and global clinical monitoring work.
  • Veristat: Specialty clinical and biometrics CRO serving small and mid-sized biotech and device sponsors with complex trial designs. Comparable to Vastrax in serving niche, expertise-intensive neuro programs with high-touch engagement.
  • Worldwide Clinical Trials: Mid-sized global CRO with a well-established neuroscience franchise spanning CNS trials and rare neurological disease. Direct competitor for Vastrax in neuro-focused clinical operations, biometrics, and regulatory services to pharma and device sponsors.

Broad incumbents

  • ICON plc: Global full-service CRO with significant CNS and neuro device exposure via the PRA Health Sciences combination. Competes for large neuro trials where scale, geographic reach, and integrated technology platforms matter.
  • IQVIA: Largest global CRO with broad neuroscience practice and dedicated neuro operations. Competes with Vastrax on enterprise neuro trials but offers materially deeper resourcing and a broader therapeutic portfolio.
  • Parexel: Large global CRO with established neurology practice and strong medical device trial capabilities. Overlaps with Vastrax in neurovascular device and neuro-pharma trial execution but at significantly larger scale.
  • Medpace: Mid-to-large full-service CRO with growing neuroscience and neuro device capabilities and a global operating footprint. Competes with Vastrax on full-service neuro trials but at meaningfully greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Vastrax social profiles

Digital presence

Vastrax financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vastrax leadership team

Management profile

Number of profiles

Profiles1 record

Vastrax funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vastrax M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vastrax

What does Vastrax do?

Vastrax is a global full-service Contract Research Organization (CRO) exclusively supporting the development of neurological therapies. It delivers a comprehensive suite of integrated services—Trial Operations, Regulatory Expertise, Study Design, Clinical Monitoring, Biometrics, Elite Site Partnerships, and Safety Services—to pharmaceutical sponsors, biotech companies, and neuro device startups across stroke, aneurysm, AI-imaging, brain-computer interface, neuromodulation, spine, and neuro-pharma programs.

Is Vastrax a public or private company?

Vastrax is a private company. It is classified as unknown and is currently operating.

When was Vastrax founded?

Vastrax was founded in 2016. It employs 11 to 50 people.

Where is Vastrax based?

Vastrax is headquartered in Waltham, United States, in the North America region.

How does Vastrax make money?

One revenue line is on record: CRO Services - Professional Services.

Who are Vastrax's main competitors?

Clinipace Worldwide is listed as an emerging player. Direct peers are Precision for Medicine, CTI Clinical Trial and Consulting Services, Premier Research, Veristat and Worldwide Clinical Trials. Broad incumbents are ICON plc, IQVIA, Parexel and Medpace.

Does Vastrax have an API?

No public API is recorded for Vastrax.

What industry is Vastrax in?

Vastrax's product category is Clinical Research Services (Contract Research Organization). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceViz.ai and Vastrax Join Forces to Accelerate Clinical Trial EnrollmentViz.ai and Vastrax announced a partnership to accelerate clinical trial enrollment for neurovascular therapies. Viz RECRUIT software, which has demonstrated 3x1 acceleration in enrollment, will become Vastrax's AI-powered recruitment platform. The collaboration aims to broaden patient diversity and speed market access for new devices.Business Wire BlogViz.ai and Vastrax Join Forces to Accelerate Clinical Trial EnrollmentViz.ai and Vastrax announced a partnership to accelerate clinical trial enrollment for neurovascular therapies. Viz RECRUIT software, which has demonstrated 3x1 acceleration in enrollment, will become Vastrax's AI-powered recruitment platform. The collaboration aims to increase access and diversity in research.PR NewswireNovel Device Shows Promise for Early Identification of Serious StrokesCerebrotech Medical Systems reported results from the VITAL study showing its non-invasive VIPS™ technology device can identify large vessel occlusion strokes and large hemorrhagic strokes with 93% sensitivity and 92% specificity, enabling faster triage of serious stroke patients in ambulances or emergency rooms. The multi-center clinical trial involved researchers from Mount Sinai, the Medical University of South Carolina, the University at Buffalo, and Baptist Medical Center Jacksonville, with data managed by Vastrax. The device, which uses low-energy electromagnetic waves to measure brain bioimpedance asymmetry, holds a CE mark but is not yet cleared for sale in the United States.